Notices. Notice; correction

301 words·~1 min read·/register/2014/09/09/2014-21369

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2014-N-0001] Advisory Committee Renewals; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration

(FDA)is correcting a notice entitled “Advisory Committee Renewals” that appeared in the **Federal Register** of August 25, 2014 (79 FR 50658). The document announced the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs. The table in the document contained several errors. This document corrects those errors. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115. SUPPLEMENTARY INFORMATION: In the **Federal Register** of Monday, August 25, 2014, in FR Doc. 2014-20017, on page 50659 the table is corrected to read: Name of committee Date of expiration Advisory Committee for Pharmaceutical Science and Clinical Pharmacology January 22, 2016. Gastrointestinal Drugs Advisory Committee March 3, 2016. Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Reproductive Health Drugs Advisory Committee) March 23, 2016. Arthritis Advisory Committee April 5, 2016. Pharmacy Compounding Advisory Committee April 25, 2016. Anesthetic and Analgesic Drugs Advisory Committee May 1, 2016. Blood Products Advisory Committee May 13, 2016. Pulmonary-Allergy Drugs Advisory Committee May 30, 2016. Drug Safety and Risk Management Advisory Committee May 31, 2016. Science Advisory Board to the National Center for Toxicological Research June 2, 2016. Peripheral and Central Nervous System Drugs Advisory Committee June 4, 2016. Psychopharmacologic Drugs Advisory Committee June 4, 2016. Transmissible and Spongiform Encephalopathies Advisory Committee June 9, 2016. Science Board to the Food and Drug Administration June 26, 2016. Allergenic Products Advisory Committee July 9, 2016. Dated: September 3, 2014. Jill Hartzler Warner, Associate Commissioner for Special Medical Programs. [FR Doc. 2014-21369 Filed 9-8-14; 8:45 am]